Quantifying Migraine’s Cognitive Toll: Real-world Evidence from the MIND Cohort

Efficacy and Safety of Symbravo® (MoSEIC(TM) Meloxicam and Rizatriptan) in Participants with Migraine Previously Treated with Oral CGRP Inhibitors: Topline Results from the EMERGE Trial

Emotion Recognition Deficits in Huntington’s Disease: A Systematic Review and Meta-analysis Across Modalities and Disease Stages